Greenwich LifeSciences, Inc. (GLSI)
NASDAQ·Healthcare·Biotechnology
$17.35
+1.31%
Mkt Cap $287.25M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$50.00
Range $50.00 – $50.00
Implied Upside
+188.2%
Consensus $50.00 vs current $17.35